Pages that link to "Q84122212"
Jump to navigation
Jump to search
The following pages link to Use of alemtuzumab and rituximab consolidation in CLL: Pros and cons (Q84122212):
Displaying 2 items.
- Emerging antibody combinations in oncology (Q37893414) (← links)
- Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trial (Q40560266) (← links)